- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
BDR Pharma gets DCGI nod for generic antibiotic drug Biapenem

Biapenem is a carbapenem used for treatment of moderate and severe bacterial infections.
New Delhi: BDR Pharmaceuticals on Friday said it has received approval from Drugs Controller General of India (DCGI) for its generic antibiotic drug Biapenem used for treatment of patients with intra-abdominal infections, lower respiratory infections, and complicated urinary tract infections.The drug from the company in the form of an injection in 300mg strength will be available in the...
New Delhi: BDR Pharmaceuticals on Friday said it has received approval from Drugs Controller General of India (DCGI) for its generic antibiotic drug Biapenem used for treatment of patients with intra-abdominal infections, lower respiratory infections, and complicated urinary tract infections.
The drug from the company in the form of an injection in 300mg strength will be available in the market shortly, BDR Pharmaceuticals said in a statement as reported by PTI.
"This drug will cover a broad spectrum of almost every infection and will be a great boon to the medical fraternity and patients," BDR Pharmaceuticals, Business Development - Director Raheel Shah said.
Biapenem is a carbapenem used for treatment of moderate and severe bacterial infections.
Medical Dialogues team had earlier reported that BDR Pharmaceuticals had launched generic Cabozantinib, used for the treatment of various types of cancer.
M.Com
Ruchika joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751